Advertisement

Drugs

pp 1–1 | Cite as

Correction to: Delafloxacin: First Global Approval

  • Anthony Markham
Open Access
Correction
  • 152 Downloads

1 Correction to: Drugs 2017;77(13):1481–6  https://doi.org/10.1007/s40265-017-0790-5

The article Delafloxacin: First Global Approval, written by Anthony Markham, was originally published Online First without open access. After publication in volume 77, issue 13, pages 1481–1486 Melinta Therapeutics, Inc. requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Melinta Therapeutics, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The ​original ​article ​has ​been ​corrected.

Copyright information

© Springer Nature 2018

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations